Events

Completed Events

18Jan
10th HiPEAC PARMA-DITAM 2016

Clarion Congress Hotel Prague, Czech Republic

19Jan
10th HiPEAC Workshop on Reconfigurable Computing

Clarion Congress Hotel Prague, Czech Republic

08Mar
Plenary Meeting - Milan, Italy

Milan, Italy

29May
pHealth 2016 international conference

Heraklion, Crete, Greece

09Jun
21st Annual Meeting of the European Haematology Association

Bella Center - Copenhagen, Denmark

10Nov
AEGLE at the iTECHLAW in Madrid

Madrid, Spain

15Nov
AEGLE at ISSE 2016 in Paris

Paris, France

17Nov
Big Data Spain

Madrid, Spain

28Mar
AEGLE at DATE2017 Conference

Laussane, Switzerland

24Apr
Informatics for Health 2017

Manchester, UK

10May
eHealth Week 2017

Malta

19Sep
Data revolution in Healthcare

Barcelona, Spain

04Oct
Impact of Big Data Analytics on Healthcare

Luxembourg, Luxembourg

16Nov
Big Data Spain 2017

Madrid, Spain

All events
Back to list

3rd International Conference on Multiple Myeloma

7th October 2016 - 9th October 2016

Milan, Italy

Outcome of multiple myeloma has dramatically improved over the last years with the introduction of novel agents. These agents have not only improved the complete remission rates, but they have resulted in tangible improvements in survival. 

Upon completion of this CME activity, participants should be able to:

Acquire insight into the current diagnostic process of multiple myeloma, staging system, and risk stratification.

Evaluate the relevance of molecular diagnostics and minimal residual disease assessment, and their relevance for clinical management decisions.

Learn about treatment state of the art, and understand some of the critical clinical management issues in the treatment of young adults and patients of older age with fit or frail conditions.

Get insight into developmental therapeutics of multiple myeloma, Waldestrom macroglobulinemia and amyloidosis including knowledge about mechanisms of action of novel therapeutic compounds, the current status of development of various targeted drugs and their promises for future clinical applications.

More details at:

Interest Form

Captcha
Required*